Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data

INTRODUCTION: The efficacy of conventional treatments for alopecia areata (AA) has been extremely variable and disappointing, with a high rate of relapse. Recent clinical trials and real-life studies have demonstrated efficacy and safety of baricitinib (an oral Janus kinase 1 and 2 inhibitor) in alo...

Descripción completa

Detalles Bibliográficos
Autores principales: De Greef, Axel, Thirion, Romane, Ghislain, Pierre-Dominique, Baeck, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613164/
https://www.ncbi.nlm.nih.gov/pubmed/37717224
http://dx.doi.org/10.1007/s13555-023-01030-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613164/
https://www.ncbi.nlm.nih.gov/pubmed/37717224
http://dx.doi.org/10.1007/s13555-023-01030-x

Ejemplares similares